Columnist Dagmar Munn has a Santa wish list for her outings over the holidays: accessible restrooms and good cutlery among ...

Widetrial is supporting an expanded access program (EAP) to bring MN-166 (ibudilast) to ALS patients ineligible for clinical ...

The Converge platform validated as many as 83% of its treatment targets in disease models, a higher success rate than usual ...

Ractigen's RAG-21, a treatment for ALS linked to mutations in the FUS gene, has been granted orphan drug designation in the U ...

A grant from the ALS Association will fund an early-stage clinical trial to test Tiziana's foralumab nasal spray in 20 ALS ...

The world's largest ALS patient-derived stem cell and biodata repository is now available to researchers globally.

Although she did everything possible to learn about ALS, columnist Juliet Taylor says the disease often left her feeling ...

Columnist Kristin Neva learns to self-apply cognitive behavioral therapy techniques, as a do-it-yourself approach has always served her well.

This November, I AM ALS, a nonprofit dedicated to helping people — both patients and family members — affected by amyotrophic lateral sclerosis (ALS), is launching a campaign focused on supporting ...